Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

June 16, 2014

Primary Completion Date

July 30, 2019

Study Completion Date

August 27, 2019

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Rociletinib

Rociletinib will be administered to patients orally

Trial Locations (91)

100

National Taiwan University Hospital, Taipei

1011

Centre Hospitalier Universitaire Vaudoise, Lausanne

2065

Royal North Shore Hospital, Sydney

2145

Westmead Hospital, Westmead

4101

Icon Cancer Centre, South Brisbane

5042

Flinders Medical Centre, Bedford Park

10461

Montefiore Medical Center, The Bronx

11217

Taipei Veterans General Hospital, Taipei

13125

Evangelische Lungenklinik Berlin, Berlin

13915

Centre Hospitalier Universitaire Hôpital Nord, Marseille

14642

University of Rochester, Rochester

19111

Fox Chase Cancer Center, Philadelphia

22031

Virginia Cancer Specialists, Fairfax

22927

LungenClinic Großhansdorf GmbH, Großhansdorf

26121

Pius Hospital Oldenburg, Oldenburg

32135

Yale University School of Medicine, New Haven

33176

Advanced Medical Specialties, Miami

33305

Chang Gung Memorial Hospital Linkou, Taoyuan District

33331

Cleveland Clinic Florida, Weston

37203

Tennessee Oncology, PLLC, Nashville

40447

China Medical University Hospital, Taichung

40705

Taichung Veterans General Hospital, Taichung

41013

Hospital Universitario Virgen del Rocio, Seville

44106

University Hospitals of Cleveland, Cleveland

44195

Cleveland Clinic, Cleveland

45122

Universitätsklinikum Essen, Essen

50937

Universitätsklinikum Köln, Cologne

53127

Universitaetsklinikum Bonn - Zentrum fuer Innere Medizin - Medizinische Klinik und Poliklink III, Bonn

55404

Minnesota Oncology Hematology, P.A, Minneapolis

55905

Mayo Clinic - Rochester, Rochester

60590

Goethe-Universität Frankfurt am Main, Frankfurt am Main

60611

Northwestern University Feinberg School of Medicine, Chicago

60612

University of Illinois Chicago, Chicago

60714

Illinois Cancer Specialists, Niles

63110

Washington University School of Medicine, St Louis

69495

Centre Hospitalier Lyon Sud, Pierre Bénité Cedex

75020

Hôpital Tenon, Paris

75028

Texas Oncology P.A., Flower Mound

75246

Texas Oncology P.A., Dallas

76014

USO - Texas Oncology P.A., Arlington

76022

Texas Oncology P.A., Bedford

77030

The Methodist Hospital, Houston

77702

Texas Oncology-Beaumont, Beaumont

78705

Texas Oncology-Austin Central, Austin

79106

Texas Oncology P.A., Amarillo

80218

Rocky Mountain Cancer Centers, LLP, Lone Tree

80336

Klinikum Innenstadt LMU, München

82131

Asklepios Fachkliniken München-Gauting, Gauting

90277

Cancer Care Associates, Redondo Beach

91328

Northridge Hospital Medical Center, Northridge

91801

UCLA Medical Center, Alhambra

92093

University of California San Diego Moores Cancer Center, La Jolla

92835

Saint Jude Heritage Healthcare, Fullerton

93309

Comprehensive Blood and Cancer Center, Bakersfield

93401

Coastal Integrative Cancer Care, San Luis Obispo

94115

University of California San Francisco, San Francisco

94805

Institut Gustave Roussy, Villejuif

95817

University of California Davis Medical Center, Sacramento

98686

Northwest Cancer Specialists, P.C., Vancouver

98902

Yakima Valley Memorial Hospital, North Star Lodge, Yakima

81501-6132

Saint Mary's Regional Cancer Center, Grand Junction

02215

Beth Israel Comprehensive Cancer Center, Boston

01805

Lahey Hospital and Medical Center, Burlington

12110-2188

New York Oncology Hematology, PC, Latham

75075-7787

Texas Oncology - Plano East, Plano

M5G 2L7

Princess Margaret Hospital, Toronto

25030 cedex

Centre Hospitalier Regional Universitaire (CHRU) de Besancon - L'Hopital Jean Minjoz, Besançon

Unknown

Institut de Cancérologie de l'Ouest - René Gauducheau, Saint-Herblain

Centre Hospitalier Universitaire Côte de Nacre, Caen

Queen Mary Hospital, Hong Kong

National Cancer Center, Goyang-si

Chungbuk National University Hospital, Chungju

Dong-A University Hospital, Busan

Asan Medical Center, Seoul

Seoul National University Hospital, Seoul

Seoul Saint Mary's Hospital, Seoul

Severance Hospital, Yonsei University Health System, Seoul

Hospital Universitari Germans Trias i Pujol, Badalona

Hospital Universitario Quirón Dexeus, Barcelona

Hospital Universitario La Paz, Madrid

1066 CX

Antoni van Leeuwenhoek Hospital, Amsterdam

1081 HV

Vrije Universiteit Medisch Centrum, Amsterdam

405-760

Gachon University Gil Medical Center, Incheon

400-711

Inha University Hospital, Incheon

135-710

Samsung Medical Center, Seoul

08035

Hospital Vall d´Hebrón, Barcelona

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

SE1 9RT

Guy's and Saint Thomas NHS Foundation Trust, London

SW3 6JJ

Royal Marsden Hospital, London

SM2 5PT

Royal Marsden NHS Trust, Sutton

NW1 2PQ

University College Hospital, London

Sponsors
All Listed Sponsors
lead

Clovis Oncology, Inc.

INDUSTRY

NCT02147990 - Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter